Page 101«..1020..100101102103..110120..»

Category Archives: Mesenchymal Stem Cells

Stem Cell Showdown: Celltex vs. the FDA

Posted: Published on January 5th, 2013

Cecelia Johnson was an artist, cellist, tap dancer, and 22-year-old college student when she was diagnosed with multiple sclerosis in 2001. The disease, in which the bodys immune system attacks the tissue protecting nerves, proceeds at its own pace: Sometimes the deterioration is halting, sometimes it can be delayed, but there is no cure. Johnsons decline was swift. Six years after her diagnosis, undone by fatigue and pain and often unable to walk, Johnson gave up on conventional medicine. In the spring of 2007 she traveled from her home in Houston to Mexico, where an American doctor gave her an infusion of adult stem cells that were supposed to regenerate her damaged tissue. I thought this guy might be peddling snake oil, says Johnson. But I would have taken snake oil. The procedure cost her $14,000. Within a few months, she began to feel better. The effects werent lasting, though, and she returned to Mexico every year until the Federal Bureau of Investigation arrested her doctor in December2011. Francisco Morales was accused of conspiracy and fraud: He wasnt a licensed doctor, and he was using umbilical-cord stem cells he bought in the U.S. for treatments that the Food and Drug … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Stem Cell Showdown: Celltex vs. the FDA

Medistem Inc. Annual Letter to Shareholders

Posted: Published on January 5th, 2013

SAN DIEGO, CA--(Marketwire - Jan 4, 2013) - Medistem Inc. ( PINKSHEETS : MEDS ) today issues the following letter to shareholders. Dear Fellow Shareholders, 2012 was marked by significant progress in the development of the Endometrial Regenerative Cell (ERC), our new universal donor "stem cell drug."Most significantly, we initiated a double blind, placebo controlled clinical study in patients with end stage heart failure, in which ERC were administered via the Medistem's patent-pending minimally invasive procedure.The clinical trial comprises three escalating doses of ERC with cohorts of 20 patients per dose.To date 14 patients have been treated with no adverse effects, thus demonstrating feasibility of the administration procedure, as well as safety of the cells.Because it is a double blind study, efficacy will not be known until the trial is completed.The clinical trial is being conducted at the Backulev Center for Cardiovascular Surgery in Moscow, Russia, by Academician Leo Bockeria.The company also initiated a 15 patient critical limb ischemia trial in China in collaboration with Shanghai Jia Fu Medical Apparatus Inc.To date two patients have been treated.The trial is based on the Medistem critical limb ischemia study that has been cleared by the FDA. In addition, we licensed from Yale … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Medistem Inc. Annual Letter to Shareholders

AllCells Releases New Line of Bioservices

Posted: Published on January 3rd, 2013

EMERYVILLE, Calif., Jan. 3, 2013 /PRNewswire/ --AllCells LLC, a leading provider of healthy & diseased hematopoietic tissues and related services to the global life science industry is proud to announce the release of a new line of Bioservices. The CRO type of Bioservices will be focusing on drug discovery, preclinical research, drug toxicity assays, and other life science research applications. Immunoassays Stem Cell Assays Flow Cytometry Services Tissue Culture Services Protein Analysis Genotyping For a complete list and more in-depth descriptions, please refer to the AllCells 2013-2014 Product Catalog. "The introduction of these CRO type of Bioservices provide essential components of hematological cell-based assays commonly used in the work-flow of drug development based research projects," commented Dr. Basha Stankovich, Manager of Bioservices. Dr. Jack Zhai, VP of Sales & Marketing added, "These Bioservices offerings combine with our 20 years of experience in hematology, which provides our customers with a range of cell-based assays within the academia/non-profit market segment." For more information about our Bioservices, please visit http://www.allcells.com/bioservices/. Full press release available here: http://www.allcells.com/blog/allcells-releases-new-line-of-bioservices/ . The rest is here: AllCells Releases New Line of Bioservices … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on AllCells Releases New Line of Bioservices

Canadian clinic first in country to harvest stem cells derived from body fat

Posted: Published on January 2nd, 2013

CTVNews.ca Staff Published Tuesday, Jan. 1, 2013 10:05PM EST Wishing that stubborn ring of belly fat would just disappear? Think twice about willing it away completely. Physicians at a Toronto clinic now consider it biological insurance that can be stored for a rainy day. Adisave, a clinic specializing in stem-cell harvesting, has begun offering storage of stem cells from human body fat, claiming the biological material can be used as a medical tool to repair and rejuvenate the body. Debra Seed opted for liposuction treatment to remove fat from her body and is paying $1,700 to have stem cells extracted, frozen and stored at Adisave-- the first clinic in the country to offer fat stem cell banking. They can put them back in my body and rejuvenate the bad cells, she said. Dr. Sammy Sliwin, a plastic surgeon and medical director at Adisave, has been working in fat grafting since 1992. He began doing research on mesenchymal stem cells in 2008. According to Sliwin, fat, or adipose tissue, contains 500 times more stem cells compared to bone marrow. Studies suggest they may have the power to repair injuries, damaged hearts and treat illness, he said. Its the most plentiful source … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Canadian clinic first in country to harvest stem cells derived from body fat

Adult Stem Cell Therapy Breakthrough Leads to Crowd Funding Campaign on Indiegogo.com for Centagen, Inc.

Posted: Published on January 1st, 2013

Centagen has developed a breakthrough stem cell therapy that rejuvenates a patient's own adult stem cells. The Company has found a way to expand a patients own stem cells in the lab millions of times while rejuvenating the cells. For example, a patients blood pleuropotent stem cells could be rejuvenated and expanded in the lab and then re-injected to repair and rejuvenate organs and tissues damaged by aging or disease. Centagen has announced a funding campaign at http://www.indiegogo.com/centagen for additonal research and development. Boulder, Colorado (PRWEB) December 31, 2012 Each of us has a limited supply of the kind of stem cells needed to rebuild, repair, and rejuvenate any part of our body. As we age, the supply and healing power of our stem cells diminishes. By providing a practically unlimited supply of one's own rejuvenated stem cells, we may keep people young and healthy for well over a century. In particular, regenerating tissues and organs prepared by expanding ones own stem cells could help with Alzheimers disease, diabetes, immune senescence, damaged heart tissue, arteriosclerosis, failing kidneys, failing hearing or eyesight, osteoporosis, weak muscles, and aged skin. The technology requires no genetic engineering of the stem cells, so the procedure … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Adult Stem Cell Therapy Breakthrough Leads to Crowd Funding Campaign on Indiegogo.com for Centagen, Inc.

GeneCell International’s Director of Operations, Jose Cirino, Organizes a Series of Educational Seminars with the …

Posted: Published on January 1st, 2013

Director of Operations to GeneCell International continues to highlight the importance of cord blood banking among the Minority Community by providing further educational programs to ensure expecting parents are well informed of the medical breakthrough Miami, Florida (PRWEB) December 31, 2012 Umbilical cord blood preservation is a process by which blood is collected from the umbilical cord of a newborn baby and is stored cryogenically in a specially-designated bank. According to the National Marrow Donor Program, cord blood contains cells that can be transfused to a patient to treat various diseases, including lymphoma and leukemia. Currently, there are approximately 80 treatable diseases and the list of illnesses continues to grow. Cord blood is rich in stem cells and because certain immune cells found in the cord blood are not mature, there is less risk for the recipients immune system to reject these cells. Cord blood can be used to treat the child from whom the blood was collected as well as some first-degree relatives who are a close genetic match, such as immediate family members. Additionally, patients can get the treatment in about three weeks - as opposed to six to eight for bone marrow from an adult donor. A … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on GeneCell International’s Director of Operations, Jose Cirino, Organizes a Series of Educational Seminars with the …

Stem Cell Therapy at IMC Dr.Omar Gonzalez – Video

Posted: Published on December 31st, 2012

Stem Cell Therapy at IMC Dr.Omar Gonzalez New Project 70 By: OmarGonzalezMD … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Stem Cell Therapy at IMC Dr.Omar Gonzalez – Video

Illinois Nano-Bio Node – BioE Seminar Series Oct. 11, 2012 – The role of cell geometry in stem cells – Video

Posted: Published on December 31st, 2012

Illinois Nano-Bio Node - BioE Seminar Series Oct. 11, 2012 - The role of cell geometry in stem cells "The role of cell geometry and adhesion ligand presentation in guiding stem cell differentiation" Kris Kilian, PhD Materials Science and Engineering, University of Illinois at Urbana-Champaign October 11, 2012 "Substrates that are designed to mimic the extracellular matrix are useful tools for studying cellular processes. Recently, we showed how micropatterning single mesenchymal stem cells can be used to reveal geometric cues that guide lineage specification. Shapes that promote a contractile cytoskeleton promote osteogenesis while shapes that promote a less organized cytoskeleton promote adipogenesis. In a separate study we found that the density and affinity of an immobilized cell adhesion ligand influences lineage specification. Surfaces presenting the high affinity cyclic-RGD peptide guide MSCs to express elevated levels of osteogenic markers. In contrast, surfaces presenting the lower affinity linear-RGD peptide promote expression of markers associated with myogenesis at high density and neurogenesis at low density of ligand. In both of these studies, the control of integrin-mediated adhesion and actomyosin contractility were found to guide specific differentiation programs. In this talk, I will present our efforts in the design of model systems that vary … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Illinois Nano-Bio Node – BioE Seminar Series Oct. 11, 2012 – The role of cell geometry in stem cells – Video

Neuvitale! – Video

Posted: Published on December 28th, 2012

Neuvitale! StemCellVitamin.net - Neuvitale-Natural Stem Cell Therapy. Stem Cells are responsible for 50% to 70% of your bodies healing and repairing! The more stem cells or "building blocks" we have available, the faster and better our organs can be repaired. Our overall health is strongly influenced by the continued availability of extra stem cells in our bodies. But as we age our natural stem cell count declines. Natural adult stem cells can migrate to damaged tissues and actually become a new heart cell, liver cell, pancreas cell or any type of tissue cell.From:vitastimViews:0 0ratingsTime:06:23More inScience Technology Read the original: Neuvitale! - Video … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Neuvitale! – Video

Mesenchymal stem cells in gynecology – Video

Posted: Published on December 26th, 2012

Mesenchymal stem cells in gynecology Mesenchymal stem cells in gynecologyFrom:mansvuViews:1 0ratingsTime:45:41More inEducation Read more: Mesenchymal stem cells in gynecology - Video … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Mesenchymal stem cells in gynecology – Video

Page 101«..1020..100101102103..110120..»

We cordially invite you to collaborate with us (as Speaker/Exhibitor/Sponsor/Media Partner) for “10th Annual Conference on Stem Cell and Regenerative Medicine” scheduled on August 13-14, 2018 in London, UK.

For meeting details visit: https://stemcell-regenerativemedicine.conferenceseries.com/